Max EFA’s are a special product
Here are some tid bits from Biotics Research rep Mike Mutzel about Max EFA’s and why they are the best fish oils available.
What do we recommend for EFA supplements?
In light of new research, we now are recommending that anyone taking omega-3 fatty acid supplements should balance the EPA and DHA with 50% GLA. That is, if you have 1500 mg of combination EPA/DHA you need 750 mg GLA. This has been well published by Floyd Chilton, PhD, from Wake Forest school of medicine. In fact, in this combination the oils will increase their anti inflammatory effect and efficacy.
Here is a list off Chiltons publications (he is the one that suggests using 2:1 ratio of combination EPA/DHA to GLA.
“providing 0.75 g GLA + 0.5 g EPA significantly decreased stimulated whole blood LTB (leukotriene), biosynthesis compared with placebo”(2)
New research is also showing that Vitamin E, in the form of gamma-tocopherol, needs to be included to any EFA supplemental protocol. Essential fatty acids are highly unstable, and easily oxidized by endogenous free radicals in the body. Their for taking gamma-tocopherol along with your EFA’s is absolutely essential.
“The beneficial effects of Fish Oil can be enhanced by the addition of vitamin E in the diet. This combination can specifically modulate the levels of IL-6, IL-10, IL-12 and TNF-α” (1)
In addition to helping to prevent lipid peroxidation, Vitamin E also helps
· insulin sensitivity
· total antioxidant status
· serum glutathione levels
· reduces oxidized LDL levels
The MAX EFA’s from XCAP is the ONLY EFA product on the product right now that contains EPA/DHA and GLA in the proper proportions along with efficacious amounts of Vitamin E in the form of gamma-tocopherol.
1) Prostaglandins Leukot Essent Fatty Acids. 2005 Dec;73(6):463-74. Epub 2005 Sep 16 Monjazeb AM, High KP, Connoy A, Hart LS, Koumenis C, Chilton FH.
2) Inhibition of leukotriene biosynthesis by a novel dietary fatty acid formulation in patients with atopic asthma: a randomized, placebo-controlled, parallel-group, prospective trial.
Clin Ther. 2003 Mar;25(3):972-9.
XCAP ( Xtreme Couture Athletic Pharmaceuticals )